| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 937 | 0 | 0 | 1.026.103 | 2.131.227 | 3.153.417 | 3.761.969 | 4.341.815 | 4.731.670 | 6.555.770 |
| Total Income - EUR | 4.034 | 11.661 | 9 | 1.042.309 | 2.139.149 | 3.153.437 | 3.761.970 | 4.341.815 | 4.731.954 | 6.555.913 |
| Total Expenses - EUR | 12.355 | 12.723 | 11.023 | 1.036.191 | 2.155.748 | 3.247.672 | 3.712.710 | 4.318.820 | 4.629.788 | 6.237.944 |
| Gross Profit/Loss - EUR | -8.321 | -1.063 | -11.014 | 6.117 | -16.599 | -94.234 | 49.261 | 22.996 | 102.166 | 317.969 |
| Net Profit/Loss - EUR | -8.321 | -1.063 | -11.014 | -4.305 | -16.599 | -94.234 | 49.261 | 22.996 | 94.313 | 252.472 |
| Employees | 0 | 0 | 2 | 7 | 21 | 26 | 29 | 30 | 30 | 27 |
Check the financial reports for the company - Poli Generika Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 295 | 0 | 0 | 0 | 0 | 0 | 4.471 | 1.047 |
| Current Assets | 49.657 | 24.230 | 16.793 | 799.327 | 1.411.887 | 1.824.107 | 1.908.762 | 2.278.378 | 3.522.535 | 3.655.581 |
| Inventories | 2.400 | 2.376 | 0 | 1.083 | 1.062 | 1.101 | 1.493 | 17.548 | 15.821 | 3.249 |
| Receivables | 32.452 | 14.839 | 14.621 | 754.160 | 1.382.672 | 1.777.802 | 1.800.594 | 2.237.419 | 3.148.401 | 3.469.895 |
| Cash | 14.805 | 7.015 | 2.172 | 44.084 | 28.152 | 45.205 | 106.675 | 23.411 | 358.314 | 182.437 |
| Shareholders Funds | -3.484 | -4.511 | -15.449 | -19.470 | -35.806 | -129.362 | -77.233 | -54.477 | 41.275 | 293.516 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 53.141 | 28.741 | 32.537 | 818.797 | 1.447.693 | 1.953.469 | 1.985.994 | 2.332.854 | 3.485.731 | 3.363.111 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Poli Generika Srl